Sunir J. Garg, MD, reflects on the recent American Academy of Ophthalmology meeting in Chicago and shares key insights on managing diabetic macular edema (DME). Dr Garg highlights new data showing ...

Researchers think they know why eye injections for “wet” AMD sometimes fail Laura Beth and Michael James Noel, of Louisa, announce the birth of their son, James Hopkins Noel. He was born at 3:46 p.m.

AMN is characterized by dark reddish macular lesions and retinal ischemia, with bilateral ocular changes noted in most patients. Retinal perfusion deficits and inner retinal changes were identified, ...

A newly published Chinese study found increased numbers of cases with acute macular neuroretinopathy (AMN) and other deficits associated with the COVID-19 outbreak, 1 reported Xiaojia Song, MD, from ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. After injury, severed axons separated from ...

Age-related macular degeneration (AMD) causes your central vision to get worse as you get older. An estimated 19.6 million people over 40 live with AMD, and nearly 1.5 million of them have their ...

The U.S. Department of Defense awarded just under $514,000 to an interdisciplinary team of researchers at the U of A to study the efficacy of “self-delivering” gene editors in the treatment of ...

This therapy delivers the proprietary tyrosine kinase inhibitor vorolanib through the bioerodible Durasert E platform, designed for patients with diabetic macular edema (DME). According to the company ...

The study was published Thursday in JAMA Ophthalmology. Advertisement Macular degeneration is the most frequent cause of irreversible vision loss in the developed world. It affects the macula ...

Returning from the 2024 American Academy of Ophthalmology Annual Meeting in Chicago, Dr Garg highlights several important studies on diabetic macular edema (DME). One key study focused on the ...